IGM Other Non Cash Items from 2010 to 2024

IGMS Stock  USD 10.43  0.97  10.25%   
IGM Biosciences Other Non Cash Items yearly trend continues to be comparatively stable with very little volatility. Other Non Cash Items will likely drop to about 4.2 M in 2024. From the period from 2010 to 2024, IGM Biosciences Other Non Cash Items quarterly data regression had r-value of  0.77 and coefficient of variation of  154.57. View All Fundamentals
 
Other Non Cash Items  
First Reported
2018-12-31
Previous Quarter
14.5 M
Current Value
656 K
Quarterly Volatility
4.7 M
 
Covid
Check IGM Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IGM Biosciences' main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Depreciation And Amortization of 8.7 M or Interest Expense of 8.3 M, as well as many indicators such as Price To Sales Ratio of 194, Dividend Yield of 0.0 or PTB Ratio of 2.25. IGM financial statements analysis is a perfect complement when working with IGM Biosciences Valuation or Volatility modules.
  
Check out the analysis of IGM Biosciences Correlation against competitors.
For more information on how to buy IGM Stock please use our How to Invest in IGM Biosciences guide.

Latest IGM Biosciences' Other Non Cash Items Growth Pattern

Below is the plot of the Other Non Cash Items of IGM Biosciences over the last few years. It is IGM Biosciences' Other Non Cash Items historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in IGM Biosciences' overall financial position and show how it may be relating to other accounts over time.
Other Non Cash Items10 Years Trend
Slightly volatile
   Other Non Cash Items   
       Timeline  

IGM Other Non Cash Items Regression Statistics

Arithmetic Mean1,821,113
Geometric Mean196,862
Coefficient Of Variation154.57
Mean Deviation2,164,285
Median27,000
Standard Deviation2,814,974
Sample Variance7.9T
Range9.3M
R-Value0.77
Mean Square Error3.5T
R-Squared0.59
Significance0.0008
Slope484,075
Total Sum of Squares110.9T

IGM Other Non Cash Items History

20244.2 M
20236.1 M
20229.3 M
20213.2 M
20202.6 M
20191.7 M

About IGM Biosciences Financial Statements

IGM Biosciences shareholders use historical fundamental indicators, such as Other Non Cash Items, to determine how well the company is positioned to perform in the future. Although IGM Biosciences investors may analyze each financial statement separately, they are all interrelated. The changes in IGM Biosciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on IGM Biosciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Other Non Cash Items6.1 M4.2 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for IGM Stock Analysis

When running IGM Biosciences' price analysis, check to measure IGM Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IGM Biosciences is operating at the current time. Most of IGM Biosciences' value examination focuses on studying past and present price action to predict the probability of IGM Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IGM Biosciences' price. Additionally, you may evaluate how the addition of IGM Biosciences to your portfolios can decrease your overall portfolio volatility.